Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 131INDUSTRY 96NIH 31NETWORK 14OTHER_GOV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Sarcoma 1Oesophagogastric Cancer 1Neoplasm Metastasis 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Lapatinib × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown
1,103 enrolled
Gastrointestinal

Oesophagogastric Cancer

NCT01730677 2014-03-12

LV

National Cancer Center, Korea

Phase 2 Unknown
150 enrolled
Breast

Breast Neoplasms

NCT01133912 2012-01-04

PGT

National Cancer Center, Korea

Phase 1 Completed
13 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡